Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis
ConclusionHAIC may significantly improve OS and provide better tumor control with mild side effects and preserved liver function in patients with advanced HCC with major PVTT compared to TACE/TAE treatment.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Chemotherapy | Eloxatin | Heart | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Radiology | Thrombosis | Urology & Nephrology